A Simple Measure to Assess Hyperinflation and Air Trapping: 1-Forced Expiratory Volume in Three Second / Forced Vital Capacity

References (22)

1. Hansen, JE. Clinical Function Testing δ Interpretation. Clinical Focus Series, 1st ed. London, Jaypee Brothers Medical Publishers, 2011.
2. Burgel PR, Bourdin A, Chanez P, Chabot F, Chaouat A, Chinet T, at al. Update on the roles of distal airways in COPD. Eur Respir Rev 2011;20:7-22.
3. Hansen JE, Sun XG, Wasserman K. Discriminating measures and normal values for expiratory obstruction. Chest 2006;129:369-77.
4. Hogg JC, McDonough JE, Sanchez PG, Cooper JD, Coxson HO, Elliott WM, et al. Micro-Computed Tomography Measurements of Peripheral Lung Pathology in Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 2009;6:546-9.
5. McNulty W, Usmani OS. Techniques of assessing small airways. Eur Clin Respir J 2014;1.
6. Morris ZQ, Coz A, Starosta D. An isolated reduction of the FEV3/FVC ratio is an indicator of mild lung injury. Chest 2013;144:1117-23.
7. Zelter M. The return of FEV3. Chest 2013;144:1089-91.
8. Lam DC, Fong DY, Yu WC, Ko FW, Lau AC, Chan JW, et al. FEV3, FEV6 and their derivatives for detecting airflow obstruction in adult Chinese. Int J Tuberc Lung Dis 2012;16:681-6.
9. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. ATS/ERS Task Force: Standardisation of lung function testing. Interpretative strategies for lung function tests. Eur Respir J 2005;26:948- 68.
10. Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, et al. ATS/ERS Task Force: Standardisation of lung function testing. General considerations for lung function testing. Eur Respir J 2005;26:153-61.
11. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. ATS/ERS Task Force: Standardisation of lung function testing. Standardisation of spirometry. Eur Respir J 2005;26:319-38.
12. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, et al. ATS/ERS Task Force: Standardisation of lung function testing. Standardisation of the measurement of lung volumes. Eur Respir J 2005;26:511-22.
13. Mohamed Hoesein FA, Zanen P, Lammers JW. Lower limit of normal or FEV1/FVC <0.70 in diagnosing COPD: an evidence-based review. Respir Med 2011;105:907-15.
14. BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS. Thorax 1997;52(Suppl 5):S1-28.
15. Kohansal R, Martinez-Camblor P, Agustí A, Buist AS, Mannino DM, Soriano JB. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med 2009;180:3-10.
16. Hansen JE, Porszasz J, Casaburi R, Stringer WW. Re-defining lower limit of normal for FEV1/FEV6, FEV1/FVC, FEV3/FEV6 and FEV3/FVC to improve detection of airway obstruction. J COPD F 2015;2:94-102.
17. Burgel PR. The role of small airways in obstructive airway diseases. Eur Respir Rev 2011;119:23-33.
18. van Veen IH, Sterk PJ, Schot R, Gauw SA, Rabe KF, Bel EH. Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma. Eur Respir J 2006;27:951-6.
19. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981;123:659-64.
20. Miller MR, Grove DM, Pincock AC. Time domain spirogram indices: their variability and reference values in nonsmokers. Am Rev Respir Dis 1985;132:1041-8.
21. Miller MR, Pincock AC, Grove DM. Patterns of spirometric abnormality in individual smokers. Am Rev Respir Dis 1985;132:1034-40.
22. US Department of Health and Human Services (DHHS) National Center for Health Statistics. Third National Health and Nutrition Examination Survey, 1988 - 1994: NHANES III Raw Spirometry Data File. Hyattsville, MD: Centers for Disease Control and Prevention; 2001.